national stem-cell therapy logo

Avid Bioservices Partners with California Institute for Regenerative Medicine (CIRM) to Provide CDMO Services for Cell and Gene Therapy (CGT) Programs


Avid Bioservices, a dedicated biologics contract development and manufacturing organization (CDMO), announced today that it has partnered with the California Institute for Regenerative Medicine (CIRM), California’s stem cell agency, to provide contract development and manufacturing (CDMO) services for cell and gene therapy (CGT) programs funded by CIRM. Through this partnership, Avid will make its CGMP […]

Cell and Gene Therapy Companies Leverage GenScript’s cGMP sgRNA Capability to Accelerate Speed to Market

PISCATAWAY, N.J., Dec. 15, 2022 /PRNewswire/ — GenScript USA Inc., the world’s leading life-science service provider, recently expanded its global current Good Manufacturing Practices (cGMP) single-guide RNA (sgRNA) manufacturing capabilities to meet the growing demand for cell and gene therapies. GenScript’s 400,000 square-foot cGMP facility enables next-generation gene and cell therapy R&D programs to advance IND filings and clinical trials. “We are […]